Parexel International (ma) Corporation
Location
Massachusetts
Founded
1983-02-28
Website
Risk Signals
451 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Parexel International (ma) Corporation
Live alerts from global media, monitored by Business Radar
2025-01-31 (biospectrumasia.com)
APAC takes centre-stage in AI-driven drug discovery
APAC takes centre-stage in AI-driven drug discovery
Read more
2024-10-03 (appliedclinicaltrialsonline.com)
FSP Partnership: A Foundation for Innovation and Patient-Guided Development
Liz Rogers, VP and Head of Global Site and Study Operations at Pfizer, discusses Pfizer's partnership with Parexel and transition to a functional service provider (FSP) model.
Read more
2024-07-08 (biospace.com)
Biopharmaceutical CMO And CRO Market Size to Hit USD 65.36 Billion by 2033
Biopharmaceutical CMO And CRO Market Size to Hit USD 65.36 Billion by 2033 - read this article along with other careers information, tips and advice on BioSpace
Read more
2024-04-26 (expresspharma.in)
Parexel partners with Palantir to accelerate clinical data delivery
Under the collaboration, Parexel will leverage Palantir’s Foundry and Artificial Intelligence Platform (AIP) to further power its clinical data platform, focused on driving clinical trial efficiency while maintaining the safety and regulatory rigor
Read more
2024-04-25 (eletsonline.com)
Parexel: First CRO to Partner with Palantir to Accelerate Clinical Data Delivery and Power Clinical Outcomes for Patients - Elets eHealth
Parexel, one of the world's largest clinical research organisations (CROs), providing the full range of Phase I to IV clinical development services, has announced a multi-year strategic partnership with Palantir Technologies Inc.
Read more
2024-01-17 (expresspharma.in)
Parexel and JFCR collaborate for cancer research
Under the agreement, JFCR will join Parexel’s Global Site Alliance network for oncology clinical trials and providing more opportunities for Japanese patients to participate in cancer research
Read more
2024-01-16 (biovoicenews.com)
Parexel announces strategic alliance with Japanese Foundation for Cancer Research - BioVoiceNews
With experience spanning more than 115 years, JFCR is Japan’s first and largest medical organization dedicated to cancer care
Read more
2024-01-07 (pharmatutor.org)
PAREXEL hiring Senior Clinical Research Associate
PAREXEL has supported the Bio-Tech and Pharmaceutical industries in helping the development of new drugs and treatments on a global basis. As a leading global biopharmaceutical service provider, they supply knowledge-based contract research, medical communications and consulting services across a
Read more
2023-10-12 (globenewswire.com)
Global Investigative Sites Recognize Parexel with the 2023 Society for Clinical Research Sites Eagle Award
Prestigious industry recognition reflects company’s commitment to the development of strong site relationships in support of patients ...
Read more